Many biotechs begin with an idea. Based on that idea, money is raised, a company is built, deals are completed, and projects are started that result in products. For this to be successful, the idea must be protected by an IP strategy that supports financing and partnering and that results in an IP portfolio that provides sufficient exclusivity to ensure a good return on investment.

In this interactive masterclass, based on practical examples and 20 years of experience in IP and licensing in the life sciences sector, you will learn how a biotech can best utilise IP in all stages of its development (from start-up to listed company with a mature product portfolio), how to incorporate IP into a partnering strategy, and how to deal with FTO issues should they occur.